Patent Assignment
Reel/Frame 035462/0486
Assignment of Assignor's Interest
Recorded: 2015-04-21
Pages: 11
Assignor
BETA CAT PHARMACEUTICALS, LLC
Executed: 2014-06-19
Assignee
BETA CAT PHARMACEUTICALS, INC.
22 FIRSTFIELD ROAD, SUITE 220, GAITHERSBURG, MARYLAND, 20878
Covered Properties
(3)
Methods for Treatment of Diseases and Disorders Related to Transducin Beta-Like Protein 1 (Tbl 1) Activity, Including Myeloproliferative Neoplasia and Chronic Myeloid Leukemia.
PCT:
PCT/US2012/063746 ↗
Methods for treatment of diseases and disorders related to transducin beta-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia.
Methods for treatment of diseases and disorders related to transducin beta-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia
Application:
61/556,245 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 6, 2014
From: HORRIGAN, STEPHEN
To: BETA CAT PHARMACEUTICALS LLC
Reel/Frame 032156/0942 →
Assignment of Assignor's Interest
Feb 6, 2014
From: BHALLA, KAPIL N
To: THE UNIVERSITY OF KANSAS MEDICAL CENTER
Reel/Frame 032157/0160 →
Assignment of Assignor's Interest
Feb 6, 2014
From: THE UNIVERSITY OF KANSAS
To: BETA CAT PHARMACEUTICALS LLC
Reel/Frame 032157/0289 →
Assignment of Assignor's Interest
Mar 27, 2014
From: BHALLA, KAPIL N
To: THE UNIVERSITY OF KANSAS
Reel/Frame 032537/0674 →
Corrective Assignment to Correct the Nature of Conveyance to Read a Corrected Assignment to Correct the Assignee's Name on Reel Number 032157/0160 Previously Recorded on Reel 032537 Frame 0674. Assignor(S) Hereby Confirms the Corrected Assignment.
Jun 19, 2014
From: BHALLA, KAPIL N
To: THE UNIVERSITY OF KANSAS; THE UNIVERSITY OF KANSAS
Reel/Frame 033203/0434 →
Change of Name
Jul 31, 2024
From: BETA CAT PHARMACEUTICALS, INC.
To: ITERION THERAPEUTICS, INC.
Reel/Frame 068235/0827 →